Lupin Limited (LUPIN) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.147x

Based on the latest financial reports, Lupin Limited (LUPIN) has a cash flow conversion efficiency ratio of 0.147x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs29.03 Billion ≈ $313.93 Million USD) by net assets (Rs197.28 Billion ≈ $2.13 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Lupin Limited's balance sheet to measure how much of total assets are equity-financed.

Lupin Limited - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Lupin Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Lupin Limited to evaluate the quality of earnings relative to operating cash generation.

Lupin Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lupin Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
HDFC Asset Management Company Limited
NSE:HDFCAMC
0.130x
Washington H Soul Pattinson & Company Ltd
AU:SOL
-0.041x
Allegro.eu S.A.
WAR:ALE
0.012x
TAISEI CORP. ADR/ 1/4
F:TKK
N/A
SON.HO.UN.ADR 1/5 SF -05
F:PHBA
N/A
Jeronimo Martins SGPS SA
LS:JMT
0.198x
DT Midstream Inc
NYSE:DTM
0.060x
Avery Dennison Corp
NYSE:AVY
0.141x

Annual Cash Flow Conversion Efficiency for Lupin Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of Lupin Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see LUPIN stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs172.94 Billion
≈ $1.87 Billion
Rs30.00 Billion
≈ $324.43 Million
0.173x -31.66%
2024-03-31 Rs143.73 Billion
≈ $1.55 Billion
Rs36.48 Billion
≈ $394.56 Million
0.254x +67.83%
2023-03-31 Rs125.43 Billion
≈ $1.36 Billion
Rs18.97 Billion
≈ $205.15 Million
0.151x +403.24%
2022-03-31 Rs122.22 Billion
≈ $1.32 Billion
Rs3.67 Billion
≈ $39.72 Million
0.030x -77.14%
2021-03-31 Rs138.58 Billion
≈ $1.50 Billion
Rs18.22 Billion
≈ $197.02 Million
0.131x +12.60%
2020-03-31 Rs125.81 Billion
≈ $1.36 Billion
Rs14.69 Billion
≈ $158.85 Million
0.117x -3.37%
2019-03-31 Rs137.89 Billion
≈ $1.49 Billion
Rs16.66 Billion
≈ $180.17 Million
0.121x -6.05%
2018-03-31 Rs136.17 Billion
≈ $1.47 Billion
Rs17.51 Billion
≈ $189.38 Million
0.129x -57.69%
2017-03-31 Rs135.32 Billion
≈ $1.46 Billion
Rs41.14 Billion
≈ $444.86 Million
0.304x +1022.36%
2016-03-31 Rs111.95 Billion
≈ $1.21 Billion
Rs-3.69 Billion
≈ $-39.90 Million
-0.033x -110.73%
2015-03-31 Rs88.98 Billion
≈ $962.30 Million
Rs27.33 Billion
≈ $295.57 Million
0.307x +7.27%
2014-03-31 Rs69.99 Billion
≈ $756.86 Million
Rs20.04 Billion
≈ $216.72 Million
0.286x +20.48%
2013-03-31 Rs52.64 Billion
≈ $569.24 Million
Rs12.51 Billion
≈ $135.29 Million
0.238x +73.36%
2012-03-31 Rs40.85 Billion
≈ $441.80 Million
Rs5.60 Billion
≈ $60.57 Million
0.137x -42.67%
2011-03-31 Rs33.33 Billion
≈ $360.41 Million
Rs7.97 Billion
≈ $86.18 Million
0.239x -8.32%
2010-03-31 Rs25.93 Billion
≈ $280.46 Million
Rs6.76 Billion
≈ $73.15 Million
0.261x -20.06%
2009-03-31 Rs14.39 Billion
≈ $155.63 Million
Rs4.70 Billion
≈ $50.78 Million
0.326x +62.70%
2008-03-31 Rs12.89 Billion
≈ $139.41 Million
Rs2.59 Billion
≈ $27.96 Million
0.201x -1.57%
2007-03-31 Rs8.73 Billion
≈ $94.45 Million
Rs1.78 Billion
≈ $19.24 Million
0.204x -8.77%
2006-03-31 Rs5.89 Billion
≈ $63.68 Million
Rs1.32 Billion
≈ $14.22 Million
0.223x +18.37%
2005-03-31 Rs4.91 Billion
≈ $53.05 Million
Rs925.60 Million
≈ $10.01 Million
0.189x -79.18%
2004-03-31 Rs4.32 Billion
≈ $46.67 Million
Rs3.91 Billion
≈ $42.29 Million
0.906x --

About Lupin Limited

NSE:LUPIN India Drug Manufacturers - Specialty & Generic
Market Cap
$12.25 Billion
Rs1.13 Trillion INR
Market Cap Rank
#1894 Global
#75 in India
Share Price
Rs2478.50
Change (1 day)
+1.44%
52-Week Range
Rs1851.80 - Rs2503.30
All Time High
Rs2503.30
About

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutica… Read more